Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis

Humbert M., Labrune P., Sitbon O., Le Gall C., Callebert J., Herve P., Samuel D., Machado R., Trembath R., Drouet L., Launay J-M., Simonneau G.

Source: Eur Respir J 2002; 20: 59-65
Journal Issue: July
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Humbert M., Labrune P., Sitbon O., Le Gall C., Callebert J., Herve P., Samuel D., Machado R., Trembath R., Drouet L., Launay J-M., Simonneau G.. Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesis. Eur Respir J 2002; 20: 59-65

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis
Source: Eur Respir Rev 2009; 18: 125-128
Year: 2009



Pulmonary arterial hypertension: an autoimmune disease?
Source: Eur Respir J 2005; 26: 986-988
Year: 2005


Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
Source: Eur Respir J 2008; 31: 343-348
Year: 2008



Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005

Reversibility of pulmonary arterial hypertension in HIV/HHV8-associated Castleman's disease
Source: Eur Respir J 2005; 26: 969-972
Year: 2005



Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Pulmonary veno-occlusive disease misdiagnosed as idiopathic pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 177-180
Year: 2009



RESPITE: Riociguat in pulmonary arterial hypertension patients with an inadequate response to phosphodiesterase type 5 inhibitors
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016


Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Changing demographics of pulmonary arterial hypertension in congenital heart disease
Source: Eur Respir Rev 2010 19: 308-313
Year: 2010



Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



The dopaminergic system in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
Source: Eur Respir J 2010; 36: 792-799
Year: 2010



Pathophysiology of pulmonary arterial hypertension
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=191
Year: 2004

Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003